SCHEMBL10126744

SCHEMBL10126744

CCOC(=O)/C=C/c1nn(C(=O)OC(C)(C)C)c2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.46
ELANE P08246 11/20 0.43
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
F2 P00734 1/20 0.41
PLAU P00749 1/20 0.41
CASP3 P42574 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38
NR1I2 O75469 1/20 0.38
PGR P06401 1/20 0.38
CYP3A4 P08684 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
CYP2C9 P11712 1/20 0.38
SLC6A2 P23975 1/20 0.38
TBXAS1 P24557 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16791413 0.87 MAP2K4 (0.39) L3MBTL1ELANENPC1RAB9AF2
SCHEMBL18098022 0.85 MAP2K4 (0.40) L3MBTL1ELANEF2PLAULMNA
SCHEMBL6282207 0.84 SRC (0.37) ELANENPC1RAB9ALMNACYP3A4
SCHEMBL6282211 0.84 SRC (0.37) ELANENPC1RAB9ALMNACYP3A4
SCHEMBL15149187 0.83 NPC1 (0.38) L3MBTL1ELANENPC1RAB9ALMNA
SCHEMBL15902469 0.80 MAP2K4 (0.43) L3MBTL1ELANENPC1RAB9AF2
SCHEMBL29443983 0.80 MAP2K4 (0.43) L3MBTL1ELANENPC1RAB9AF2
SCHEMBL30786187 0.78 MAP2K4 (0.42) L3MBTL1ELANENPC1RAB9AF2
SCHEMBL8739431 0.78 ELANE (0.70) ELANEF2PLAU
SCHEMBL4312058 0.76 MAP2K4 (0.38) L3MBTL1ELANENPC1RAB9AF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2800748-B1 CYCLIC AMIDE DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE AND USES THEREOF CONNEXIOS LIFE SCIENCES PVT LTD (IN) 2017-03-29 EP disclosed
US-9453014-B2 Cyclic amide derivatives as inhibitors of 11-β-hydroxysteroid dehydrogenase and uses thereof CONNEXIOS LIFE SCIENCES PVT. LTD. (IN) 2016-09-27 US disclosed
US-20150158860-A1 CYCLIC AMIDE DERIVATIVES AS INHIBITORS OF 11 - BETA - HYDROXYSTEROID DEHYDROGENASE AND USES THEREOF CONNEXIOS LIFE SCIENCES PVT. LTD. (IN) 2015-06-11 US disclosed
EP-2412711-A1 INDAZOLEPROPIONIC ACID AMIDE COMPOUND Mitsubishi Tanabe Pharma Corporation (JP) 2012-02-01 EP disclosed
US-20120016117-A1 INDAZOLEPROPIONIC ACID AMIDE COMPOUND MITSUBISHI TANABE PHARMA CORPORATION (JP) 2012-01-19 US disclosed
US-8022059-B2 Indazole acrylic acid amide compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-09-20 US disclosed
US-20100256108-A1 INDAZOLE ACRYLIC ACID AMIDE COMPOUND MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120016117-A1 INDAZOLEPROPIONIC ACID AMIDE COMPOUND SCN9A, SCN1A, SCN1B L3MBTL1 3398/4885ELANE 3717/4885NPC1 1482/4885
US-20150158860-A1 CYCLIC AMIDE DERIVATIVES AS INHIBITORS OF 11 - BETA - HYDROXYSTEROID DEHYDROGENASE AND USES THEREOF HSD11B1, HSD11B2, HSD17B1 L3MBTL1 3615/4885ELANE 1902/4885NPC1 338/4885
US-20100256108-A1 INDAZOLE ACRYLIC ACID AMIDE COMPOUND KCNH2, KCNH3, KCNJ11 L3MBTL1 2702/4885ELANE 3560/4885NPC1 2242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.